We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Severe Features of Systemic Juvenile Idiopathic Arthritis in Patients With Congenital Heart Disease.
- Authors
Aires, Barbara Pontes; Wobma, Holly; Samad, Aaida; Chandler, Mia T.; Chang, Margaret H.; Dedeoglu, Fatma; Fishman, Martha P.; Klouda, Timothy; Levin, Jonathan; Halyabar, Olha; Saleeb, Susan F.; Tworetzky, Wayne; Son, Mary Beth F.; Newburger, Jane W.; Casey, Alicia; Henderson, Lauren A.
- Abstract
Objective. To describe the clinical features of patients with congenital heart disease (CHD) who subsequently developed systemic juvenile idiopathic arthritis (sJIA). Methods. We conducted a retrospective review of patients diagnosed with CHD and sJIA at our institution. Detailed clinical, laboratory, and radiographic data were collected from the medical record and reviewed with each patient's primary medical team. Results. Five patients with sJIA and CHD were identified. Each child had a unique cardiac anatomy, but all the patients required surgical repair during the first year of life. Four children had thymectomies at the time of cardiac surgery. Classic signs of sJIA such as fever (n = 5), rash (n = 5), and arthritis (n = 4) developed after surgical intervention in all the patients. The individuals in this cohort displayed risk factors associated with severe sJIA, including disease onset before 2 years of age (n = 5), elevated interleukin 18 levels (n = 5), baseline eosinophilia prior to initiation of biologic disease-modifying antirheumatic drugs (n = 4), and positivity for HLA-DRB1*15:01 alleles (n = 4). Macrophage activation syndrome (MAS) occurred in 3 patients and sJIA-associated lung disease (sJIA-LD) was identified in 4 patients. Two children died from complications of their cardiac and/or pulmonary disease. Conclusion. We identified an association between CHD and severe forms of sJIA. Although these findings will need to be confirmed in larger, multicenter cohorts, the results highlight the importance of considering a diagnosis of sJIA in children with CHD and remaining vigilant for complications such as MAS and sJIA-LD.
- Subjects
JUVENILE idiopathic arthritis; MACROPHAGE activation syndrome; CONGENITAL heart disease; CARDIAC patients; ANTIRHEUMATIC agents; FEVER
- Publication
Journal of Rheumatology, 2024, Vol 51, Issue 8, p811
- ISSN
0315-162X
- Publication type
Article
- DOI
10.3899/jrheum.2024-0180